在阿片类药物使用障碍患者中滥用普雷加巴林的模式,风险和临床挑战:一个案例系列
Nikhil Gurjar1, Tanu Singla2, Nikhil Gautam3
1Psychiatry, Gurjars Clinic, Mumbai, IND.
Cureus
|June 23, 2025
概括
在阿片类药物使用障碍 (OUD) 患者中,普雷加巴林的滥用正在增加,增强了快乐感,并作为阿片类药物的替代品. 这种组合增加了风险,需要更严格的法规和减少危害的策略.
科学领域:
- 药理学 药理学 是一个学科.
- 成 药物 药物 药物 药物
- 临床神经学 临床神经学
背景情况:
- 普雷加巴林是一种 gabapentinoid,用于治疗神经病痛和.
- 观察到pregabalin的滥用越来越多,特别是在阿片类药物使用障碍 (OUD) 患者中.
- 普雷加巴林与阿片类药物的协同作用加剧了高兴感.
研究的目的:
- 介绍一系列具有并发性OUD和高剂量普雷加巴林依赖症的个体病例.
- 详细说明他们的戒断症状,同时出现的物质使用和治疗干预措施.
- 为了突出与OUD患者滥用普雷加巴林相关的风险.
主要方法:
- 案例系列方法.
- 三名患者的临床观察和记录.
- 对戒断症状,物质使用模式和治疗结果的分析.
主要成果:
- 患者在停止高剂量普雷加巴林时表现出严重的戒断症状.
- 同时出现的物质使用使临床情况和治疗复杂化.
- 成功管理需要量身定制的干预措施,解决OUD和pregabalin依赖.
结论:
- 在OUD患者中,Pregabalin的滥用是由增加的高兴感和戒断的自我治疗驱动的.
- 这种滥用会增加呼吸抑制和严重戒断的风险.
- 更严格的法规,处方教育和降低危害对于减轻普雷加巴林滥用至关重要.
相关概念视频
Analgesia and Pain Management
822
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
822
Opioid Analgesics: Synthetic and Semisynthetic Opioids
453
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
453
Opioid Analgesics: Morphine and Other Natural Cogeners
382
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
382
Drug Abuse and Addiction: Pharmacological Phenomena
663
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
663
Opioid Receptors: Overview
2.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.0K
Antiepileptic Drugs: Potassium Channel Activators
289
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
289


